HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis.

Abstract
Angiogenesis is a prerequisite for tumour progression and is highly regulated by growth factors and cytokines a number of which also stimulate the production of nitric oxide. Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthesis. Asymmetric dimethylarginine is metabolised by dimethylarginine dimethylaminohydrolase. To study the effect of dimethylarginine dimethylaminohydrolase on tumour growth and vascular development, the rat C6 glioma cell line was manipulated to overexpress the rat gene for dimethylarginine dimethylaminohydrolase I. Enhanced expression of dimethylarginine dimethylaminohydrolase I increased nitric oxide synthesis (as indicated by a two-fold increase in the production of cGMP), expression and secretion of vascular endothelial cell growth factor, and induced angiogenesis in vitro. Tumours derived from these cells grew more rapidly in vivo than cells with normal dimethylarginine dimethylaminohydrolase I expression. Immunohistochemical and magnetic resonance imaging measurements were consistent with increased tumour vascular development. Furthermore, dimethylarginine dimethylaminohydrolase activity was detected in a series of human tumours. This data demonstrates that dimethylarginine dimethylaminohydrolase plays a pivotal role in tumour growth and the development of the tumour vasculature by regulating the concentration of nitric oxide and altering vascular endothelial cell growth factor production.
AuthorsV Kostourou, S P Robinson, J E Cartwright, G St J Whitley
JournalBritish journal of cancer (Br J Cancer) Vol. 87 Issue 6 Pg. 673-80 (Sep 09 2002) ISSN: 0007-0920 [Print] England
PMID12237779 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Endothelial Growth Factors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Nitric Oxide
  • Amidohydrolases
  • dimethylargininase
  • Cyclic GMP
Topics
  • Amidohydrolases (genetics, metabolism, pharmacology)
  • Animals
  • Astrocytoma (metabolism, pathology)
  • Blotting, Northern
  • Blotting, Western
  • Brain Neoplasms (blood supply, metabolism, pathology)
  • Cell Division (physiology)
  • Cell Movement
  • Cells, Cultured
  • Cyclic GMP (metabolism)
  • DNA Primers (chemistry)
  • Endothelial Growth Factors (metabolism)
  • Endothelium, Vascular (metabolism)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glioblastoma (metabolism, pathology)
  • Glioma (blood supply, metabolism, pathology)
  • Humans
  • Lymphokines (metabolism)
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms, Experimental (blood supply, metabolism, pathology)
  • Neovascularization, Pathologic (metabolism)
  • Nitric Oxide (metabolism)
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: